Bioventus (BVS) Cash from Investing Activities (2020 - 2026)

Bioventus (BVS) has reported Cash from Investing Activities for 7 consecutive years, with -$2.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Investing Activities fell 79.69% year-over-year to -$2.5 million; the trailing twelve-month figure through Jun 2026 stood at -$4.1 million (down 118.71% YoY), and the FY2025 full-year result was -$3.2 million, down 114.14% from the prior year.
• Cash from Investing Activities declined to -$2.5 million in Q2 2026 per BVS's latest filing, from -$574000.0 in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $45.0 million in Q3 2023 and bottomed at -$56.3 million in Q4 2022.
• Historically, Cash from Investing Activities has averaged -$4.0 million across 5 years, with a median of -$913000.0 in 2024.
• The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities sank 1864.69% in 2022, then jumped 4178.51% in 2024.
• Over 5 years, Cash from Investing Activities stood at -$3.4 million in 2022, then surged by 82.63% to -$591000.0 in 2023, then surged by 4178.51% to $24.1 million in 2024, then tumbled by 102.41% to -$580000.0 in 2025, then slumped by 324.14% to -$2.5 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$2.5 million, -$574000.0, and -$580000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.